We can help you determine whether a lip flip, lip filler, or both will provide the look you want
In a Phase 1 randomized, double-blind, placebo-controlled trial involving obese adults (NCT04478708), AMG 133 exhibited good safety and tolerability profiles and demonstrated significant dose-dependent weight loss effects
Ultimately, understanding carnitine's role in the body can empower individuals to make informed nutritional choices that support their long-term health
The SURMOUNT-1 72-week clinical trial showed those taking tirzepatide lost an average of 16.0% of their body weight on the 5 mg dose, 21.4% on the 10 mg dose, and 22.5% on the 15 mg dose, compared to 2.4% with placebo
Suitability depends entirely on the patient's health profile and what a licensed provider determines after a full clinical evaluation